These findings and the apparent neuroprotective effects of MLN4924 in our iPSC models highlight the therapeutic potential of this compound and calls for further investigation into the roles of protein NEDDylation in TDP-43 biology and ALS. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.